04693159001
Roche
cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail
Tablets provided in EASYpacks
Sinónimos:
Protease Inhibitor Tablets
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Seleccione un Tamaño
30 TABS
$269.000
$269.000
Disponible para envío el09 de abril de 2025Detalles
Seleccione un Tamaño
Cambiar Vistas
30 TABS
$269.000
About This Item
Código UNSPSC:
12352204
NACRES:
NA.21
$269.000
Disponible para envío el09 de abril de 2025Detalles
Productos recomendados
Formulario
tablet
envase
pkg of 30 tablets (individually packed in foil blister packs)
fabricante / nombre comercial
Roche
concentración
(Starting concentration: 1 tablet contains protease inhibitors sufficient for a 10 ml cell extract.)
técnicas
inhibition assay: suitable
solubilidad
aqueous buffer: soluble
water: soluble
Absorción
0.08 at 280 nm
temp. de almacenamiento
2-8°C
Categorías relacionadas
Descripción general
cOmplete, Mini, EDTA-free tablets, inhibit a broad spectrum of serine and cysteine proteases. In contrast to other cOmplete tablets they do not contain EDTA, leaving the stability and the function of metal-dependant proteins unaffected. The affinity purification of Poly-His-tagged fusion proteins using IMAC (Immobilized Metal Affinity Chromatography) is also facilitated (no dialysis necessary).
Due to the optimized composition of the tablets they show excellent inhibition of serine and cysteine proteases, and are well suited for the protection of proteins isolated from animal tissues, plants, yeast, and bacteria. cOmplete, Mini, EDTA-free tablets, contains both irreversible and reversible protease inhibitors. Metallo- and aspartic proteases are not inhibited.
cOmplete Mini, EDTA-free Tablets are identical to cOmplete Mini Tablets, the only difference being that no EDTA or other chelating (e.g. EGTA) agents are included.
Due to the optimized composition of the tablets they show excellent inhibition of serine and cysteine proteases, and are well suited for the protection of proteins isolated from animal tissues, plants, yeast, and bacteria. cOmplete, Mini, EDTA-free tablets, contains both irreversible and reversible protease inhibitors. Metallo- and aspartic proteases are not inhibited.
cOmplete Mini, EDTA-free Tablets are identical to cOmplete Mini Tablets, the only difference being that no EDTA or other chelating (e.g. EGTA) agents are included.
Especificidad
Mixture of several protease inhibitors. For the inhibition of serine, cysteine, but not metalloproteases.
Aplicación
cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail has been used as a component of
- nonidet P-40 (NP-40) buffer for the preparation of cell lysate of neuroblastoma cells[1]
- tissue lysis buffer for homogenisation and lysis of prefrontal cortex tissues[2]
- ice-cold radioimmunoprecipitation assay (RIPA) buffer for the lysis of Chinese hamster ovary (CHO-K1) cells[3]
cOmplete™, Mini, EDTA-free, is used for the inhibition of serine and cysteine proteases in bacterial, yeast, plant, and animal cell extracts.[4][5][6]
cOmplete, Mini, EDTA-free Tablets, are used for the inhibition of proteolytic activity in small volumes (up to 10 ml) in which EDTA may interfere with protein stability (e.g., metal-containing proteins) or subsequent assays. Since EDTA interferes with IMAC (Immobilized Metal Affinity Chromatography), cOmplete, Mini, EDTA-free, is preferentially used in the isolation process of Poly-His-tagged fusion proteins.
If it is necessary to inhibit proteolytic activity in a large volume (up to 50 ml), we recommend to use cOmplete, EDTA-free.
cOmplete, Mini, EDTA-free Tablets, are used for the inhibition of proteolytic activity in small volumes (up to 10 ml) in which EDTA may interfere with protein stability (e.g., metal-containing proteins) or subsequent assays. Since EDTA interferes with IMAC (Immobilized Metal Affinity Chromatography), cOmplete, Mini, EDTA-free, is preferentially used in the isolation process of Poly-His-tagged fusion proteins.
If it is necessary to inhibit proteolytic activity in a large volume (up to 50 ml), we recommend to use cOmplete, EDTA-free.
Características y beneficios
- Convenience: Simply push the quick-dissolving tablet through the foil packaging of the EASYpack into your buffer.
- Complete protection: Instantly protect your proteins against a broad range of proteases (see Table 1).
- Flexible: Protect proteins in extracts from almost any tissue or cell, including animals, plants, yeast, bacteria, or fungi.
- Safe: Choose non-toxic inhibitors that pose no risk to you or those around you.
Envase
30 individually packed cOmplete Protease Inhibitor Cocktail Tablets in foil blisters. Each tablet is sufficient for a volume of 10 ml solution.
Calidad
Performance-tested with pancreas extract.
Forma física
Tablets in foil blister packs
Nota de preparación
Working concentration: 1 tablet per 10 ml extraction solution
Working solution: Handling
Carefully push the tablet through the foil packaging using the base of your thumb (not fingernail) to prevent the breakage of tablets.
Preparation of Working Solution
One cOmplete Mini EDTA-free tablet is sufficient for the inhibition of the proteolytic activity in 10 ml extraction solution. When very high proteolytic activity is present, one tablet should be used for 7 ml extraction buffer. Tablets can be added directly to the extraction medium. Alternatively a stock solution (7 X conc.) can be prepared.
Stock solution (7 X conc.)
Dissolve one cOmplete Mini EDTA-free tablet in 1.5 ml dist. water or in 1.5 ml 100 mM phosphate buffer, pH 7.0.
Storage conditions (working solution): The stock solution can be stored at 2 to 8 °C for 1 to 2 weeks, or at least 12 weeks at -15 to -25 °C.
Working solution: Handling
Carefully push the tablet through the foil packaging using the base of your thumb (not fingernail) to prevent the breakage of tablets.
Preparation of Working Solution
One cOmplete Mini EDTA-free tablet is sufficient for the inhibition of the proteolytic activity in 10 ml extraction solution. When very high proteolytic activity is present, one tablet should be used for 7 ml extraction buffer. Tablets can be added directly to the extraction medium. Alternatively a stock solution (7 X conc.) can be prepared.
Stock solution (7 X conc.)
Dissolve one cOmplete Mini EDTA-free tablet in 1.5 ml dist. water or in 1.5 ml 100 mM phosphate buffer, pH 7.0.
Storage conditions (working solution): The stock solution can be stored at 2 to 8 °C for 1 to 2 weeks, or at least 12 weeks at -15 to -25 °C.
Reconstitución
Soluble in aqueous buffers, or add directly to extraction media. Alternatively, prepare 7x stock solutions in 1.5 ml water or 100 mM phosphate buffer, pH 7.0. Stock solution is stable for 1-2 weeks at 2 to 8 °C, or at least 12 weeks at -15 to -25 °C. Can be used in thiol-containing solutions at 15 to 25 °C.
Almacenamiento y estabilidad
Store at 2 to 8 °C. (storage at -15 to -25 °C is also possible)
Otras notas
For life science research only. Not for use in diagnostic procedures.
Información legal
cOmplete is a trademark of Roche
Palabra de señalización
Warning
Frases de peligro
Consejos de prudencia
Clasificaciones de peligro
Eye Irrit. 2 - Skin Irrit. 2
Código de clase de almacenamiento
11 - Combustible Solids
Clase de riesgo para el agua (WGK)
WGK 2
Punto de inflamabilidad (°F)
does not flash
Punto de inflamabilidad (°C)
does not flash
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Smruthi Vijayaraghavan et al.
Molecular cancer therapeutics, 19(10), 2044-2056 (2020-08-05)
Small molecule inhibitors targeting mutant EGFR are standard of care in non-small cell lung cancer (NSCLC), but acquired resistance invariably develops through mutations in EGFR or through activation of compensatory pathways such as cMet. Amivantamab (JNJ-61186372) is an anti-EGFR and
GBA RNAi but not catalytic inhibition of glucocerebrosidase with Conduritol-beta-epoxide increases levels of total alpha-synuclein in SH-SY5Y cells
Zurbruegg M, et al.
Neuroscience Letters, 706, 217-222 (2019)
Claudin-2 expression levels in ulcerative colitis: Development and validation of an in-situ hybridisation assay for therapeutic studies
Randall K, et al.
PLoS ONE, 11(9), e0162076-e0162076 (2016)
Douglas J Hermes et al.
Journal of neuroinflammation, 17(1), 345-345 (2020-11-20)
Human immunodeficiency virus type-1 (HIV-1) and opiates cause long-term inflammatory insult to the central nervous system (CNS) and worsen disease progression and HIV-1-related neuropathology. The combination of these proinflammatory factors reflects a devastating problem as opioids have high abuse liability
Takuto Hayashi et al.
The Journal of biological chemistry, 295(37), 13008-13022 (2020-07-22)
Yeasts and fungi generate Ca2+ signals in response to environmental stresses through Ca2+ channels essentially composed of Cch1 and Mid1. Cch1 is homologous to the pore-forming α1 subunit of animal voltage-gated Ca2+ channels (VGCCs) and sodium leak channels nonselective (NALCNs)
Contenido relacionado
Select different protease inhibitor types based on your needs to prevent protein degradation during isolation and characterization and safeguard proteins in sample prep.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico
